Roche : REGEN-COV(TM) antibody cocktail is active against SARS-CoV-2 variants first identified in the UK and South Africa

Investor Update REGEN-COV(TM) antibody cocktail is active against SARS-CoV-2 variants first identified in the UK and South Africa

Dear Investor,

Please find attached a press release from our partner Regeneron:

https://investor.regeneron.com/news-releases/news-release-details/regen-covtm-antibody-cocktail-active-against-sars-cov-2-variants

Do not hesitate to contact us for any further questions.

With best regards,

Roche Investor Relations
Dr. Karl Mahler Phone: [phone] e-mail: [e-mail]	Jon Kaspar Bayard Phone: [phone] e-mail: [e-mail]
Dr. Sabine Borngräber Phone: [phone] e-mail: [e-mail]	Dr. Bruno Eschli Phone: [phone] e-mail: [e-mail]
Dr. Birgit Masjost Phone: [phone] e-mail: [e-mail]	Dr. Gerard Tobin Phone: [phone] e-mail: [e-mail]
Investor Relations North America
Loren Kalm Phone: [phone] e-mail: [e-mail]	Dr. Lisa Tuomi Phone: [phone] e-mail: [e-mail]